Clinical Trial Update: A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy [Phase 3]

View source ↗

Summary

Phase 3 study assessing the efficacy and safety of Topiramate in patients with epilepsy; the trial completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Seizures

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Epilepsy, Seizures | Phase 3 | Status: COMPLETED